Isabel Mestres: The Doer
Global health has become very good at diagnosing problems but far less effective at implementing solutions. That gap is where Isabel Mestres has built her career. As CEO of City Cancer Challenge, she is known not as a theorist or…
OncoCorridor
As a medical student, we had a lecture on how to deliver bad news.Then, as an oncology fellow, we had it again.And as frontline clinicians, we practice it every day.…
Bente Mikkelsen: “Success is Something We Build Together”
From the bedside to global reform, and why equity must be engineered, not hoped for “I think I chose medicine because it gave all the opportunities to address people, both…
NEWS
CancerWorld #114 (April 2026)
In oncology, we are trained to deliver hope alongside difficult truths. We speak about survival rates, probabilities, and outcomes. In conflict settings, those terms lose stability. What does survival mean when hospitals are destroyed, treatments cannot reach patients, and people…
CONTENTS
ARTICLES
Pancreatic Cancer Europe at 10: Turning the Tide on Europe’s Deadliest Common Cancer
In the quieter corners of European health policy, where attention is often fragmented and political capital fiercely contested, pancreatic cancer has long remained an uncomfortable outlier—aggressive, difficult to detect, and historically underprioritised. Yet, as Europe confronts an evolving cancer burden,…
